Advertising of Drugs and Dietary Supplements
GRATA International’s specialists of the Pharmaceuticals & Healthcare sector released a new publication on Advertising of drugs and dietary supplements.
GRATA International Legal Series (GILS): Corporate law
The GRATA International Legal Series (the “GILS”) is a distinctive legal handbook, offering essential legal insights and practical tips for conducting business across jurisdictions where GRATA International operates.
Highest Ranking in Patent Litigation by IAM Patent 1000 2024 for 10th Consecutive Year
Lee & Ko has been named to this year’s IAM Patent 1000 in Patent Litigation, receiving the highest band ranking of Gold for the 10th consecutive year and “Highly Recommended” in Patent Transactions again for the third year running.
bpv Huegel advises Zentrasport on the transfer of the operating business to ANWR GROUP
The company transfer also successfully secures the future of SPORT 2000 in Austria.
Bär & Karrer Advises Banque Cantonale de Genève on Capital Increase for La Foncière
Bär & Karrer is pleased to announce its role as legal counsel to Banque Cantonale de Genève in the recent capital increase of La Foncière,
Homburger advised Santhera in connection with its up to CHF 69 m Royalty and Debt Financing
On June 18, 2024, Santhera Pharmaceuticals Holding AG (SIX: SANN) announced that it had entered into a royalty monetization financing totaling up to USD 38 m with R-Bridge, an affiliate of CBC Group,
Navigating Dubai’s Rental Market: Insights from Galadari
As Dubai’s rental market sees a surge in prices and activity, concerns have been raised by tenants facing illegal evictions and steep rent hikes.
GSK Stockmann advises GRR on acquisition of Edeka store in Munich
GSK Stockmann advised asset and investment manager GRR Real Estate Management GmbH (GRR REM) on the acquisition of an Edeka supermarket in the east of Munich for a special AIF fund.
Homburger advised ZKB as Sole Lead Manager of SGKB’s CHF 200 m Tier 2 issuance
On May 30, 2024, St.Galler Kantonalbank AG (SGKB) successfully issued CHF 200 m 2.4% Tier 2 bonds due 2034.
Rights Issue of Solara Active Pharma Sciences Limited
DSK Legal advised and assisted Solara Active Pharma Sciences Limited (the “Company”) in connection with the filing of the letter of offer dated May 9,